Quantcast

Latest Tetralogy of Fallot Stories

2010-05-27 13:50:14

Pediatric Heart Network study is largest clinical trial of treatment of patients with congenital heart disease Infants born with a severely underdeveloped heart who undergo a newer surgical procedure are more likely to survive their first year and not require a heart transplant than those who have a more traditional surgical procedure, according to a report by researchers supported by the National Heart, Lung, and Blood Institute (NHLBI), which is part of the National Institutes of Health....

2010-05-27 07:34:00

ATLANTA, May 27 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), an implantable biological medical device and cardiovascular tissue processing company, announced today that it will participate in the Jefferies 2010 Global Life Sciences Conference at The Grand Hyatt Hotel in New York City. Steven G. Anderson, president and chief executive officer of CryoLife, Inc., will present a corporate overview on Tuesday, June 8, 2010 at 9:30 a.m., Eastern Time. CryoLife's live presentation may...

2010-04-15 07:34:00

ATLANTA, April 15 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), an implantable biological medical device and cardiovascular tissue processing company, announced today that 2010 first quarter financial results will be released on Wednesday, April 28, 2010. On that day, the Company will hold a teleconference call and live webcast at 10:00 a.m. Eastern Time to discuss the results, followed by a question and answer session hosted by Steven G. Anderson, president and chief executive...

2010-04-13 07:34:00

ATLANTA, April 13 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), an implantable biological medical device and cardiovascular tissue processing company, announced today that the lawsuit filed by Medafor, Inc. against Steven G. Anderson, CryoLife's chairman, president and chief executive officer, in November 2009 was settled. The matter was mediated on April 6, 2010, with Myron S. Greenberg serving as mediator. The settlement does not require that Mr. Anderson make any payments to...

2010-03-24 16:01:00

ATLANTA, March 24 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), an implantable biological medical device and cardiovascular tissue processing company, announced today that it has withdrawn its $2.00 per share proposal to acquire Medafor, Inc. CryoLife previously notified the Medafor board of its intention to withdraw its offer in five business days. Based on the limited information that Medafor has made available to its shareholders, CryoLife continues to believe that the Medafor...

2010-02-02 15:24:00

ATLANTA, Feb. 2 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), an implantable biological medical device and cardiovascular tissue processing company, announced today that it has purchased approximately 740,000 additional shares of Medafor's common stock from Medafor shareholders for $2.00 per share. Based on the most recent information available to CryoLife, the company now owns approximately 11 percent of Medafor and continues to be Medafor's largest shareholder. CryoLife has...

2010-02-01 07:34:00

ATLANTA, Feb. 1 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), a biomaterials, medical device and tissue processing company, announced today that 2009 fourth quarter and year end financial results will be released on Thursday, February 18, 2010. On that day, the Company will hold a teleconference call and live webcast at 10:00 a.m. Eastern Time to discuss the results, followed by a question and answer session hosted by Steven G. Anderson, president and chief executive officer of...

2009-11-23 08:14:00

ATLANTA, Nov. 23 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), an implantable biological medical device and cardiovascular tissue processing company, announced today that it is scheduled to participate in the upcoming Piper Jaffray 21st Annual Health Care Conference at The New York Palace Hotel on December 1, 2009. Steven G. Anderson, president and chief executive officer of CryoLife, Inc., will provide a corporate overview regarding CryoLife and recent developments and host a...

2009-11-11 07:35:00

ATLANTA, Nov. 11 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), an implantable biological medical device and cardiovascular tissue processing company, announced today that Steven G. Anderson, president and chief executive officer of CryoLife, Inc., is scheduled to present in the upcoming Lazard Capital Markets Sixth Annual Healthcare Conference on Wednesday, November 18, 2009 at 1:15 pm ET in New York City. CryoLife's live presentation may be accessed through its Web site,...

2009-10-26 10:42:00

Multicenter study in 30 children and young adults shows good early outcomes BOSTON, Oct. 26 /PRNewswire-USNewswire/ -- Children born with certain heart defects have impaired blood flow from the right ventricle to the pulmonary artery leading to the lungs, requiring implanted devices (known as right-ventricular outflow tract conduits) to maintain the flow. However, these conduits fail over time, and children typically face multiple open-heart operations during their lives to reopen the...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related